Skip to content
The Policy VaultThe Policy Vault

TasignaMedica

Acute lymphoblastic leukemia (Philadelphia chromosome-positive)

Initial criteria

  • age ≥ 15 years
  • Philadelphia chromosome-positive acute lymphoblastic leukemia

Approval duration

1 year